BIO

Bio-Rad Laboratories, Inc.
$304.36
+3.38 (+1.12%)
Mkt Cap 8.23B
Volume 248,855
52W Range 236.73-343.12
Sector Healthcare
Beta 1.08
EPS (TTM) 6.11
P/E Ratio 49.81
Revenue (TTM) 2.59B
Rev Growth (5Y) +0.3%
EPS Growth (5Y) -26.3%
AlphaVal · Fair Value
What we estimate one share is worth
$763.57
Undervalued strong signal
60.1% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Stable Earnings Power
30.0 / 100 pillar composite (overridden)
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 2.58B 2.57B 2.67B 2.80B 2.92B 2.55B 2.31B 2.29B 2.16B 2.07B 2.02B 2.18B
Net Income 759.90M (1.84B) (637.32M) (3.63B) 4.25B 3.81B 1.76B 361.00M 114.74M 28.12M 113.09M 88.84M
EPS 27.87 -65.36 -21.82 -121.79 142.61 127.86 58.93 12.10 4.12 0.88 3.74 3.08
Free Cash Flow 374.60M 266.20M 218.26M 80.29M 535.72M 476.41M 359.37M 155.67M (10.99M) 74.50M 72.84M 136.83M
FCF / Share 13.74 9.44 7.47 2.70 17.96 16.00 12.04 5.22 -0.37 2.53 2.50 4.74
Operating CF 532.20M 455.20M 374.94M 194.45M 669.46M 584.97M 457.90M 285.49M 104.14M 216.07M 186.21M 273.31M
Total Assets 10.58B 9.36B 12.30B 13.50B 17.80B 12.97B 8.01B 5.61B 4.27B 3.85B 3.71B 3.34B
Total Debt 1.53B 1.37B 1.41B 1.39B 223.38M 225.74M 651.18M 439.43M 435.00M 434.52M 434.18M 435.98M
Cash & Equiv 531.80M 488.10M 403.80M 434.21M 470.78M 662.21M 660.67M 431.53M 383.82M 456.26M 457.55M 413.25M
Book Value 7.45B 6.57B 8.74B 9.62B 13.69B 9.88B 5.76B 4.02B 2.93B 2.58B 2.49B 2.19B
Return on Equity 0.10 -0.28 -0.07 -0.38 0.31 0.39 0.31 0.09 0.04 0.01 0.05 0.04
BIO News
Noveris Health Sciences Joins the Biotechnology Innovation Organization (BIO)
Jul 17, 2026 01:35 PM · thenewswire.com
BIO-key Regains Compliance with Nasdaq Listing Rules; Nasdaq Trading Resumes on Wednesday, July 8th
Jul 07, 2026 03:58 AM · globenewswire.com
Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention
Jul 02, 2026 04:00 AM · globenewswire.com
BIO-key Showcases Passwordless & Biometric Identity Solutions at Jordan Banking Cybersecurity Workshop in Amman on July 6th
Jul 02, 2026 12:00 AM · globenewswire.com
Bio-Rad: Activist Involvement Highlights Value-Unlocking Potential
Jul 01, 2026 09:33 PM · seekingalpha.com
Is It Too Late to Buy Bio-Rad Laboratories Inc (BIO) After 6.5% Rally? GF Value Says Undervalued
Jun 25, 2026 02:48 PM · gurufocus.com
HKSTP Leads Largest-Ever Hong Kong Delegation to BIO 2026 Showcasing Life and Health Tech Strength
Jun 24, 2026 02:25 AM · thenewswire.com
BIO CEO says more consistency needed in FDA review process
Jun 23, 2026 12:34 PM · reuters.com
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?
Jun 22, 2026 01:44 PM · fool.com
Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention
Jun 22, 2026 12:03 PM · globenewswire.com